Clinical Trials Sponsored by Par Pharmaceutical, Inc.

Total 5132 results

Par Pharmaceutical, Inc.
PRA Health Sciences

Terminated

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Anorexia | Weight Loss | Cachexia

United States
Par Pharmaceutical, Inc.
PRA Health Sciences

Terminated

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Anorexia | Weight Loss | Cachexia

United States
Par Pharmaceutical, Inc.

Completed

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Torsemide Tablets Under Fed Conditions

Healthy
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

To Determine the Bioequivalence Study Under Fasting

Canada
Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Completed

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Healthy

United States
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions

Healthy
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions

Healthy
Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Completed

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

To Determine Bioequivalence Under Fed Conditions

United States
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

To Determine the Bioequivalence Study Under Fed

Canada
Par Pharmaceutical, Inc.
AAI Clinic

Completed

Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
Par Pharmaceutical, Inc.
AAI Clinic

Completed

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc.
SFBC Anapharm

Completed

Bioavailability Study of Propranolol Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
SFBC Anapharm

Completed

Bioavailability Study of Propranolol Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Terminated

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa

Otitis Externa

United States, Puerto Rico
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Terminated

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes

Otitis Media in Patients With Tympanostomy Tubes

United States
Par Pharmaceutical, Inc.
Novum Pharmaceutical Research Services

Completed

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

To Determine the Bioequivalence Study Under Fasting
Par Pharmaceutical, Inc.
SFBC Ft. Myers, Inc

Completed

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

To Determine the Bioavailability of Tranylcypromine

United States
Par Pharmaceutical, Inc.
Covance; SFBC Anapharm

Terminated

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension

Healthy

United States
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Par Pharmaceutical, Inc.
Cetero Research, San Antonio

Completed

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

To Determine the Bioequivalence Under Fasting Conditions

United States
Par Pharmaceutical, Inc.
BASi Clinical Research Unit

Completed

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

United States
Par Pharmaceutical, Inc.
Cetero Research, San Antonio

Completed

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc.
Cetero Research, San Antonio

Completed

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions
K-PAX Pharmaceuticals, Inc.

Unknown

The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome

Chronic Fatigue Syndrome (CFS) | Myalgic Encephalomyelitis (ME)

United States
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Ultragenyx Pharmaceutical Inc
PRA Health Sciences

Recruiting

Mucopolysaccharidosis VII Disease Monitoring Program

Sly Syndrome | Mucopolysaccharidosis VII | MPS VII | MPS 7

United States, Germany, Brazil, Argentina, France, Netherlands, Portugal, Spain, Turkey
Indonesia University
Ferron Par Pharmaceuticals

Completed

Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery

Cataract

Indonesia
FORUM Pharmaceuticals Inc
PRA Health Sciences

Completed

EVP-6124 Renal Impairment Study

Renal Impairment

Czech Republic, Hungary
Enanta Pharmaceuticals, Inc
PRA Health Sciences

Completed

A Study of EDP-297 in Healthy Subjects

NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

Netherlands
Enanta Pharmaceuticals, Inc
PRA Health Sciences

Completed

Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects

Hepatitis B

United States
FORUM Pharmaceuticals Inc
PRA Health Sciences

Completed

EVP-6124 Hepatic Impairment Study

Hepatic Impairment

Czech Republic, Poland, Slovakia
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Roswell Park Cancer Institute
AVEO Pharmaceuticals, Inc.

Withdrawn

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

Stage III Renal Cell Cancer | Stage II Renal Cell Cancer
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States

Clinical Trials Sponsored by Par Pharmaceutical, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations